News

2 Tumor Surgeries Lead to Similar Results, Different Recovery Times

Removing a pituitary tumor through the nostrils with an endoscope led to shorter recovery times for patients with Cushing’s disease than for those who had the surgery through the traditional microscopic approach, a study reports. However, similar remission, recurrence, and complication rates were found between patients, regardless of the…

Drug Interaction Results in Cushing’s Syndrome in HIV Patient

A man with a known history of human immunodeficiency virus (HIV) infection and asthma developed Cushing’s syndrome after taking Tybost (cobicistat) together with fluticasone, according to a report from Spain. Tybost is a antiretroviral medicine booster, while fluticasone is a corticosteroid. The condition occurred because Tybost slows down how fast…

Single-incision Subxiphoid Surgery Used for Ectopic Tumor

A minimally invasive chest surgery using a single-incision subxiphoid approach was used to effectively remove a tumor in the thymus of a 29-year-old woman with ectopic Cushing’s syndrome, as described in a recent case report. The muscle-sparing incision causes less trauma and potentially could reduce post-surgical pain and shorten recovery…

Bleeding in Pituitary May Complicate Diagnosis of Cushing’s Disease

Children and adolescents with Cushing’s disease who have subclinical bleeding near their disease-driving tumors may respond differently to tests used to diagnose the disease, compared with patients without this bleeding, according to a new study. These differences may complicate the diagnostic workup of these patients and “should be incorporated…

New Data Support Long-term Efficacy, Safety of Isturisa

Treatment with Isturisa (osilodrostat) normalized urine cortisol levels up to nearly 1.5 years in people with Cushing’s disease, according to data from the Phase 3 LINC-4 clinical trial. Data from another Phase 3 trial, LINC-3 (NCT02180217), showed that testosterone levels were generally stable among Cushing’s patients treated with…